ReviewCurrent opinion in immunology2016

Promises and pitfalls for recombinant oligoclonal antibodies-based therapeutics in cancer and infectious disease.

Davide Corti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.